DIMENSIONAL FUND ADVISORS LP

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 354204 AUSTIN, TX

Position in ZVRA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$13,749,707

+$8,578,954 QoQ

Shares Held

958,836

+72.8% QoQ

Ownership

1.61%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#12

of 158 holders

Holding Since

Jun 2022

13 quarters on record

Voting authority Sole 91% Shared 5% None 3%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. ZVRA ranks #67 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,749,707	958,836	+72.8%	Shares	Sole	2026-08-11
2026-03-31	$5,170,753	554,802	+259.2%	Shares	Sole	2026-05-07
2025-12-31	$1,384,014	154,466	+522.8%	Shares	Sole	2026-02-12
2024-09-30	$172,112	24,800	-4.4%	Shares	Sole	2024-11-07
2024-06-30	$127,125	25,944	0.0%	Shares	Sole	2024-08-09
2024-03-31	$150,475	25,944	-40.5%	Shares	Sole	2024-05-10
2023-12-31	$285,612	43,605	-19.1%	Shares	Sole	2024-02-07
2023-09-30	$259,748	53,890	+0.0%	Shares	Sole	2023-11-09
2023-06-30	$274,797	53,882	0.0%	Shares	Sole	2023-08-09
2023-03-31	$296,351	53,882	+2.2%	Shares	Sole	2023-05-12
2022-12-31	$242,066	52,738	+0.0%	Shares	Sole	2023-02-09
2022-09-30	$328,985	52,722	+2.1%	Shares	Sole	2022-11-10
2022-06-30	$230,394	51,658	—	Shares	Sole	2022-08-12
No filing history on record for this holder in this stock.